Results 131 to 140 of about 11,699 (159)

Maintaining versus switching antiviral therapy in chronic hepatitis B patients with low-level viremia. [PDF]

J Virus Erad
Wang Y, Li L, Song C, Zhou J, Li Y, Sahar M, Wang M, Tao Y, Zhou T, He F, Lu J, Lei X, Chen E.   +12 more
europepmc   +1 more source

Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV Infection. [PDF]

Viruses
Barbu RE, Ignat MD, Bogdan Goroftei RE, Baltă AAȘ, Lutenco V, Bulza V, Stoian VI, Cambrea SC, Dumea E, Baroiu L.   +9 more
europepmc   +1 more source

HBV RNA at 6 months after nucleos(t)ide analogues treatment can predict antiviral efficacy in chronic hepatitis B patients. [PDF]

BMC Gastroenterol
Xie Y, Zhang X, Yang X, Zheng S, Zhang S, Zhang X, Kang H, Duan X, Cai W, Yin P, Ma X, Liu J, Lu F, Dai L, Feng B.   +14 more
europepmc   +1 more source

Elebsiran and pegylated-IFNα: Progress toward a functional cure for chronic hepatitis B. [PDF]

JHEP Rep
Battistella S, Protzer U, Forns X.
europepmc   +1 more source

Comparative Efficacy of Bulevirtide, Interferons, and Nucleos(t)ide Analogs for Chronic Hepatitis Delta: A Systematic Review and Network Meta-Analysis. [PDF]

Int J Hepatol
Karkra R, Mohsen M, Pagán-Busigó JE, Shamsian E, Bebawy M, Rella S, Tafesh Z, Gaglio P.   +7 more
europepmc   +1 more source

Chronic comorbidities, concomitant medications, and treatment patterns of chronic hepatitis B patients receiving nucleos(t)ide analogue therapy: a hospital claims database study in Japan. [PDF]

BMC Infect Dis
Nakamoto D, Ohata E, Yuda M, Fukui N, Makino N, Kanamori R, Aoki N, Kanazawa A, Mori H, Nishizaki Y, Yokokawa H, Yano Y, Naito T.   +12 more
europepmc   +1 more source

Propofol infusion in critically ill patients is not associated with mitochondrial dysfunction or altered serum interleukin levels in the early sepsis response. [PDF]

Crit Care Sci
Nedel WL, Portela LV.
europepmc   +1 more source

Pyrimidine Nucleos(t)ide Therapy in Patients With Thymidine Kinase 2 Deficiency: A Multicenter Retrospective Chart Review Study. [PDF]

Neurology
Domínguez-González C, Chiang C, Colson AO, Rebollo Mesa I, Baixauli E, Quan J, VanMeter S, Hirano M.   +7 more
europepmc   +1 more source

Effects of different therapeutic methods on the 90-day prognosis of patients with HBV-ACLF: A systematic review and network meta-analysis. [PDF]

Medicine (Baltimore)
Hua Y, Liu H, He Y, Liu S, Xin Y.
europepmc   +1 more source

Hepatitis B Surface Antigen Loss and Improved Clinical Outcomes in US Individuals With Chronic Hepatitis B Virus Infection. [PDF]

J Viral Hepat
Drysdale M, Chang R, Wang S, Coutinho A, Gielen V, Man T, Song R, Duh MS, Khalili M, Theodore D.   +9 more
europepmc   +1 more source